Director, CLL Center & Institute Physician; Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology Dana-Farber Cancer Institute; Harvard Medical School Boston, Massachusetts
Learning Objectives:
Incorporate guideline recommendations for cytogenetic analysis and minimal residual disease (MRD) monitoring into the care of patients with CLL/SLL